Cantarelli L, Pestana Grafina D, Gonzalez Perez A, Garcia Gil S, et al. Efficacy and Safety of Erenumab, Galcanezumab, and Fremanezumab in the Treatment of Drug-Resistant Chronic Migraine: Experience in Real Clinical Practice. Ann Pharmacother 2022 Aug 18:10600280221118402. doi: 10.1177/10600280221118402.
PMID: 35979920